David Baer, MD: A passion for cancer research

David Baer, MD, cofounded the KP Oncology Clinical Trials program in the 1980s. He has enrolled significant numbers of patients in these trials, and helped expand the regional effort into a national KP program. As a leading member of the Northern California Central Research Committee for most of his career, he provides valuable experience in the practicality of research within Kaiser Permanente.
Read More

Depressed pregnant women more likely to eat poorer diets, Kaiser Permanente analysis finds

Pregnant women with depression were more likely to eat poor diets with a higher intake of empty calories and lower intake of greens, beans, and fruit, according to an analysis of 1,160 adult pregnant women who were treated at Kaiser Permanente Northern California.
Read More

Eight Weeks or Twelve? Kaiser Permanente Study Shows Shorter Hepatitis C Regimen Effective in Black Patients

A new study shows that a treatment regimen of 8 weeks for hepatitis C may be just as effective as 12 weeks in black patients. The study also showed that more people overall can take advantage of the shorter treatment durations, which has important implications for access given the medication’s high cost.
Read More